Daniel Grow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Grow has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
John Nulsen
The Center for Advanced Reproductive Services, Division of Reproductive Endocrinology and Infertility, University of Connecticut School of Medicine, Farmington, Connecticut
3 shared publicationsLawrence Engmann
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Connecticut School of Medicine, Farmington, USA
3 shared publicationsArti Taggar
Univ Connecticut, UConn Hlth, Hlth Ctr, Farmington, CT 06030 USA
2 shared publications- Claudio A. Benadiva
Center for Advanced Reproductive Services, Department of Obstetrics and Gynecology, University of Connecticut School of Medicine, Farmington, Connecticut
2 shared publications Claudio Benadiva
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Connecticut School of Medicine, Farmington, USA
2 shared publications- Katherine G. Koniares
Fellow, The Center for Advanced Reproductive Services, Department of Obstetrics and Gynecology, University of Connecticut School of Medicine, Farmington, Connecticut, USA
2 shared publications
Latest Publications
- 31 March 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (5) , 1663-1670
Ovulatory cycle frozen embryo transfer yields similar pregnancy outcomes to programmed transfer while avoiding painful injections
Purpose Optimal endometrial preparation is essential for the transfer of a euploid embryo. Recent works have shown advantages of ovulatory cycle frozen-thawed embryo transfer (Ovu-FET) for simplicity, implantation rate, and reduction of hypertensive disorders of pregnancy; however, few women over age 40 years were included in these studies. This study compared pregnancy outcomes in patients aged 40–45 years between Ovu-FET and programmed cycle FET (PC-FET). Methods Retrospective cohort study in a university-affiliated fertility center. Two hundred eighty-seven FET cycles with euploid embryo transfer between 2015 and 2022 were included, with 116 cycles utilizing the PC-FET and 171 the Ovu-FET protocol. The use of letrozole was permitted for patients with irregular cycles. The primary outcome was ongoing pregnancy rate with secondary outcomes including pregnancy rate, clinical pregnancy rate, biochemical rate, and clinical loss rate. Multivariate regression was utilized to adjust for potential covariates. Results The ongoing pregnancy rates were similar between the Ovu-FET versus PC-FET groups (62.6% vs. 58.6%, P = 0.50). Pregnancy rates (77.2% vs. 82.8%, P = 0.25) and clinical pregnancy rates (69.5% vs. 68.1%, P = 0.79) were also similar. Clinical loss rates were similar between the two groups (7.0% vs. 9.5%, P = 0.41). Biochemical loss rates were slightly lower for the Ovu-FET versus PC-FET groups (7.6% vs. 14.7%, P = 0.06) without reaching statistical significance. Conclusion Our study supports the use of Ovu-FET in women aged 40 years and older undergoing euploid embryo transfers. The results should strengthen confidence in the use of Ovu-FET for older patients.
- 31 March 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (5) , 1663-1670
Ovulatory cycle frozen embryo transfer yields similar pregnancy outcomes to programmed transfer while avoiding painful injections
Purpose Optimal endometrial preparation is essential for the transfer of a euploid embryo. Recent works have shown advantages of ovulatory cycle frozen-thawed embryo transfer (Ovu-FET) for simplicity, implantation rate, and reduction of hypertensive disorders of pregnancy; however, few women over age 40 years were included in these studies. This study compared pregnancy outcomes in patients aged 40–45 years between Ovu-FET and programmed cycle FET (PC-FET). Methods Retrospective cohort study in a university-affiliated fertility center. Two hundred eighty-seven FET cycles with euploid embryo transfer between 2015 and 2022 were included, with 116 cycles utilizing the PC-FET and 171 the Ovu-FET protocol. The use of letrozole was permitted for patients with irregular cycles. The primary outcome was ongoing pregnancy rate with secondary outcomes including pregnancy rate, clinical pregnancy rate, biochemical rate, and clinical loss rate. Multivariate regression was utilized to adjust for potential covariates. Results The ongoing pregnancy rates were similar between the Ovu-FET versus PC-FET groups (62.6% vs. 58.6%, P = 0.50). Pregnancy rates (77.2% vs. 82.8%, P = 0.25) and clinical pregnancy rates (69.5% vs. 68.1%, P = 0.79) were also similar. Clinical loss rates were similar between the two groups (7.0% vs. 9.5%, P = 0.41). Biochemical loss rates were slightly lower for the Ovu-FET versus PC-FET groups (7.6% vs. 14.7%, P = 0.06) without reaching statistical significance. Conclusion Our study supports the use of Ovu-FET in women aged 40 years and older undergoing euploid embryo transfers. The results should strengthen confidence in the use of Ovu-FET for older patients.
- 30 September 2024
- Published by Elsevier in Fertility and Sterility
- Vol. 122 (6) , 1012-1013
An acorn is not an oak tree…
- 30 September 2024
- Published by Elsevier in Fertility and Sterility
- Vol. 122 (6) , 1012-1013
An acorn is not an oak tree…
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e305
IN LETROZOLE-STIMULATED FET CYCLES, HOW WORRIED SHOULD WE BE ABOUT A LOW ESTRADIOL LEVEL?
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e305
IN LETROZOLE-STIMULATED FET CYCLES, HOW WORRIED SHOULD WE BE ABOUT A LOW ESTRADIOL LEVEL?
- Open Access
- 24 May 2023
- Published by Elsevier in F&S Reports
- Vol. 4 (3) , 245-250
Macroprolactinemia: a mini-review and update on clinical practice
- 24 May 2023
- Published by Elsevier in F&S Reports
- Vol. 4 (3) , 245-250
Open AccessMacroprolactinemia: a mini-review and update on clinical practice
- 12 January 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 119 (3) , 442-443
We created uterine imperfection, but when do we need to fix it?
- 12 January 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 119 (3) , 442-443
We created uterine imperfection, but when do we need to fix it?
- 9 June 2022
- Published by Springer Nature in Reproductive Sciences
- Vol. 29 (7) , 1983-1987
Access to Fertility Care in Geographically Underserved Populations, a Second Look
Infertility has a prevalence of up to 16% worldwide and is on the rise in developed nations, largely due to pursuing childbearing at advanced reproductive ages. Advances in assisted reproductive technology have benefitted socioeconomically advantaged patients disproportionately. High costs of fertility care are largely responsible for this disparity; however, patients in rural areas also face barriers in accessing both gynecology and reproductive endocrinology subspecialty care. Here, focusing on the USA, we discuss fertility care in geographically underserved areas and low-resource settings, and the impact on reproductive outcomes. Increased innovation to improve patient access to fertility care such as assisted reproductive technology is critical for ensuring equity. Remote monitoring is frequently performed by fertility centers, but partnership with local gynecologists has also been demonstrated to be an effective assisted reproductive technology monitoring method. Telehealth is now in mainstream use and the continued application to reduce geographic barriers to infertility patients is imperative. Partnership between local gynecologists and reproductive endocrinology and infertility specialists may improve patient access to fertility care and provide the unique benefits of continuity and ongoing local social support.
- 9 June 2022
- Published by Springer Nature in Reproductive Sciences
- Vol. 29 (7) , 1983-1987
Access to Fertility Care in Geographically Underserved Populations, a Second Look
Infertility has a prevalence of up to 16% worldwide and is on the rise in developed nations, largely due to pursuing childbearing at advanced reproductive ages. Advances in assisted reproductive technology have benefitted socioeconomically advantaged patients disproportionately. High costs of fertility care are largely responsible for this disparity; however, patients in rural areas also face barriers in accessing both gynecology and reproductive endocrinology subspecialty care. Here, focusing on the USA, we discuss fertility care in geographically underserved areas and low-resource settings, and the impact on reproductive outcomes. Increased innovation to improve patient access to fertility care such as assisted reproductive technology is critical for ensuring equity. Remote monitoring is frequently performed by fertility centers, but partnership with local gynecologists has also been demonstrated to be an effective assisted reproductive technology monitoring method. Telehealth is now in mainstream use and the continued application to reduce geographic barriers to infertility patients is imperative. Partnership between local gynecologists and reproductive endocrinology and infertility specialists may improve patient access to fertility care and provide the unique benefits of continuity and ongoing local social support.
- 11 March 2021
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 38 (6) , 1441-1447
Reduction in multiple pregnancy rate in donor oocyte–recipient gestational carrier (GC) in vitro fertilization (IVF) cycles in the USA with single-embryo transfer and preimplantation genetic testing
Purpose To evaluate the utilization of single-embryo transfer (SET) and preimplantation genetic testing (PGT) in gestational carrier IVF cycles in the USA with donor oocyte and examine the impact on live birth and multiple gestation. Methods Retrospective cohort study using the Society of Assisted Reproductive Technology (SART) clinic database of 4776 donor oocyte–recipient IVF cycles in which a GC was used. The cycles were separated into 4 groups by use of PGT and number of embryos transferred as follows: (1) PGT and single-embryo transfer (PGT-SET); (2) PGT and multiple embryo transfer (PGT-MET); (3) no PGT and SET (NoPGT-SET); (4) no PGT and MET (NoPGT-MET). Primary outcomes were live birth rate (LBR) and multiple pregnancy rate (MPR). Results More than one blastocyst was transferred in 48.7% (2323/4774) of the cycles. When ≥1 blastocyst was transferred, with or without the use of PGT, the MPR was 45.5% and 42.0%, respectively. In comparison, in the PGT-SET and NoPGT-SET groups, the MPR was 1.4% (8/579) and 3.3% (29/883), respectively. Live birth rates increased with the use of PGT-A and with MET. Conclusion This study shows that SET, with or without PGT, is associated with a significantly reduced MPR in donor oocyte–recipient GC IVF cycles while maintaining high LBR. It also demonstrates that many infertility centers in the USA are not adhering to ASRM embryo transfer guidelines. Our findings highlight an opportunity to increase GC safety, which ultimately may lead to widened access to this increasingly restricted service outside the USA.
- 11 March 2021
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 38 (6) , 1441-1447
Reduction in multiple pregnancy rate in donor oocyte–recipient gestational carrier (GC) in vitro fertilization (IVF) cycles in the USA with single-embryo transfer and preimplantation genetic testing
Purpose To evaluate the utilization of single-embryo transfer (SET) and preimplantation genetic testing (PGT) in gestational carrier IVF cycles in the USA with donor oocyte and examine the impact on live birth and multiple gestation. Methods Retrospective cohort study using the Society of Assisted Reproductive Technology (SART) clinic database of 4776 donor oocyte–recipient IVF cycles in which a GC was used. The cycles were separated into 4 groups by use of PGT and number of embryos transferred as follows: (1) PGT and single-embryo transfer (PGT-SET); (2) PGT and multiple embryo transfer (PGT-MET); (3) no PGT and SET (NoPGT-SET); (4) no PGT and MET (NoPGT-MET). Primary outcomes were live birth rate (LBR) and multiple pregnancy rate (MPR). Results More than one blastocyst was transferred in 48.7% (2323/4774) of the cycles. When ≥1 blastocyst was transferred, with or without the use of PGT, the MPR was 45.5% and 42.0%, respectively. In comparison, in the PGT-SET and NoPGT-SET groups, the MPR was 1.4% (8/579) and 3.3% (29/883), respectively. Live birth rates increased with the use of PGT-A and with MET. Conclusion This study shows that SET, with or without PGT, is associated with a significantly reduced MPR in donor oocyte–recipient GC IVF cycles while maintaining high LBR. It also demonstrates that many infertility centers in the USA are not adhering to ASRM embryo transfer guidelines. Our findings highlight an opportunity to increase GC safety, which ultimately may lead to widened access to this increasingly restricted service outside the USA.
- 11 July 2020
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 37 (7) , 1589-1591
Donor egg is the best second choice for many infertile couples: real progress in overcoming age-related fertility is not here yet
- 11 July 2020
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 37 (7) , 1589-1591
Donor egg is the best second choice for many infertile couples: real progress in overcoming age-related fertility is not here yet
- Open Access
- 9 August 2018
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 35 (10) , 1919-1921
In vitro fertilization with granulosa cell tumor: a report of two cases
- 9 August 2018
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 35 (10) , 1919-1921
Open AccessIn vitro fertilization with granulosa cell tumor: a report of two cases